drugset
drugset / Trial / NCT02458781

Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth

NCT02458781 ↗

Phase 4 Unknown 180 enrolled San Antonio Military Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy of ciprofloxacin versus metronidazole versus placebo in eradication of small intestinal bacterial overgrowth (SIBO).

Timeline

Start
2015-01
Primary completion
2018-01
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 500 mg Oral
Comparator Metronidazole Small molecule 500 mg Oral

Indications

small intestinal bacterial overgrowth